Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

341

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

October 31, 2005

Conditions
Smokers
Interventions
BIOLOGICAL

CYT002-NicQb

Trial Locations (3)

1011

University Hospital Lausanne (CHUV), Lausanne

8029

Lungenzentrum Hirslandenklinik Zuerich, Zurich

9007

Kantonsspital St. Gallen, Sankt Gallen

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY